Cancer Research The Future of Cancer Research: Science and Patient Impact  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 11, 653-657, September 1, 1951]
© 1951 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Adelsberger, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Adelsberger, L.

Differences in Immunologic Reactions of Red Blood Cells of a Tumor-susceptible (C3H) and a Tumor-resistant (C57) Mouse Strain*

Lucie Adelsberger

( Laboratory Division of Montefiore Hospital, New York, N.Y.)

1. Hemagglutination tests with red blood cells of normal mice and antitumor rabbit sera revealed a difference between C3H and C57 erythrocytes as to rate and degree of agglutination. A more or less transitory mid-zonal weak agglutination of C3H red blood cells was observed with serum dilutions in the range of 1:4 to 1:32.
2. Red blood cells of C3H mice with spontaneous breast tumor reacted differently than red blood cells of nontumorous C3H mice. They did not show the mid-zonal weak agglutination.
3. Mixtures of antitumor rabbit serum and tumor suspension agglutinated C3H and C57 red blood cells in a different manner. The C57 agglutination was weak initially and either persisted or gradually increased. The C3H agglutination varied widely.
4. Fresh materials such as tumor, erythrocytes, and possibly serum, as well as time and temperature, are important factors for the proper application of this hemagglutination test with antitumor sera.

* Aided by a grant from the Damon Runyon Memorial Fund.

Received 2/16/51.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1951 by the American Association for Cancer Research.